Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M211424200 on December 11, 2002

J. Biol. Chem., Vol. 278, Issue 13, 11167-11174, March 28, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/13/11167    most recent
M211424200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, W.
Right arrow Articles by Fields, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, W.
Right arrow Articles by Fields, A. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Role of Cyclooxygenase 2 in Protein Kinase C beta II-mediated Colon Carcinogenesis*

Wangsheng Yu, Nicole R. Murray, Capella Weems, Lu Chen, Huiping Guo, Richard Ethridge, Jeffrey D. Ceci, B. Mark Evers, E. Aubrey Thompson, and Alan P. FieldsDagger

From the Sealy Center for Cancer Cell Biology and the Departments of Pharmacology and Toxicology, Human Biological Chemistry and Genetics and Surgery, The University of Texas Medical Branch, Galveston, Texas 77555-1048

Elevated expression of protein kinase C beta II (PKCbeta II) is an early promotive event in colon carcinogenesis (Gokmen-Polar, Y., Murray, N. R., Velasco, M. A., Gatalica, Z., and Fields, A. P. (2001) Cancer Res. 61, 1375-1381). Expression of PKCbeta II in the colon of transgenic mice leads to hyperproliferation and increased susceptibility to colon carcinogenesis due, at least in part, to repression of transforming growth factor beta type II receptor (TGF-beta RII) expression (Murray, N. R., Davidson, L. A., Chapkin, R. S., Gustafson, W. C., Schattenberg, D. G., and Fields, A. P. (1999) J. Cell Biol., 145, 699-711). Here we report that PKCbeta II induces the expression of cyclooxygenase type 2 (Cox-2) in rat intestinal epithelial (RIE) cells in vitro and in transgenic PKCbeta II mice in vivo. Cox-2 mRNA increases more than 10-fold with corresponding increases in Cox-2 protein and PGE2 production in RIE/PKCbeta II cells. PKCbeta II activates the Cox-2 promoter by 2- to 3-fold and stabilizes Cox-2 mRNA by at least 4-fold. The selective Cox-2 inhibitor Celecoxib restores expression of TGF-beta RII both in vitro and in vivo and restores TGFbeta -mediated transcription in RIE/PKCbeta II cells. Likewise, the omega -3 fatty acid eicosapentaenoic acid (EPA), which inhibits PKCbeta II activity and colon carcinogenesis, causes inhibition of Cox-2 protein expression, re-expression of TGF-beta RII, and restoration of TGF-beta 1-mediated transcription in RIE/PKCbeta II cells. Our data demonstrate that PKCbeta II promotes colon cancer, at least in part, through induction of Cox-2, suppression of TGF-beta signaling, and establishment of a TGF-beta -resistant, hyperproliferative state in the colonic epithelium. Our data define a procarcinogenic PKCbeta II right-arrow Cox-2 right-arrow TGF-beta signaling axis within the colonic epithelium, and provide a molecular mechanism by which dietary omega -3 fatty acids and nonsteroidal antiinflammatory agents such as Celecoxib suppress colon carcinogenesis.


* This work was supported by grants from the National Cancer Institute (to A. P. F.) (CA81436 and CA56869).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: The Sealy Center for Cancer Cell Biology, The University of Texas Medical Branch, 301 University Blvd., MRB 9.104, Galveston, TX 77555-1048; Tel.: 409-747-1935; Fax: 409-747-1938; E-mail: afields@utmb.edu.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
A. P. Fields, S. R. Calcagno, M. Krishna, S. Rak, M. Leitges, and N. R. Murray
Protein Kinase C{beta} Is an Effective Target for Chemoprevention of Colon Cancer
Cancer Res., February 15, 2009; 69(4): 1643 - 1650.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C.-W. Lin, W.-C. Hou, S.-C. Shen, S.-H. Juan, C.-H. Ko, L.-M. Wang, and Y.-C. Chen
Quercetin inhibition of tumor invasion via suppressing PKC{delta}/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells
Carcinogenesis, September 1, 2008; 29(9): 1807 - 1815.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Li and I. B. Weinstein
Protein Kinase C {beta} Enhances Growth and Expression of Cyclin D1 in Human Breast Cancer Cells
Cancer Res., December 1, 2006; 66(23): 11399 - 11408.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. A. Teicher
Protein kinase C as a therapeutic target.
Clin. Cancer Res., September 15, 2006; 12(18): 5336 - 5345.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Shimojo, S. Jesmin, S. Zaedi, S. Maeda, M. Soma, K. Aonuma, I. Yamaguchi, and T. Miyauchi
Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta1 and phosphorylated JNK
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H835 - H845.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Nakagawa, J. L. Oliva, D. Kothapalli, A. Fournier, R. K. Assoian, and M. G. Kazanietz
Phorbol Ester-induced G1 Phase Arrest Selectively Mediated by Protein Kinase C{delta}-dependent Induction of p21
J. Biol. Chem., October 7, 2005; 280(40): 33926 - 33934.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. P. Regala, C. Weems, L. Jamieson, J. A. Copland, E. A. Thompson, and A. P. Fields
Atypical Protein Kinase C{iota} Plays a Critical Role in Human Lung Cancer Cell Growth and Tumorigenicity
J. Biol. Chem., September 2, 2005; 280(35): 31109 - 31115.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Fujimori, K. Kadoyama, and Y. Urade
Protein Kinase C Activates Human Lipocalin-type Prostaglandin D Synthase Gene Expression through De-repression of Notch-HES Signaling and Enhancement of AP-2{beta} Function in Brain-derived TE671 Cells
J. Biol. Chem., May 6, 2005; 280(18): 18452 - 18461.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Liu, W. Su, E. A. Thompson, M. Leitges, N. R. Murray, and A. P. Fields
Protein Kinase C{beta}II Regulates Its Own Expression in Rat Intestinal Epithelial Cells and the Colonic Epithelium in Vivo
J. Biol. Chem., October 29, 2004; 279(44): 45556 - 45563.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhang, P. Z. Anastasiadis, Y. Liu, E. A. Thompson, and A. P. Fields
Protein Kinase C (PKC) {beta}II Induces Cell Invasion through a Ras/Mek-, PKC{iota}/Rac 1-dependent Signaling Pathway
J. Biol. Chem., May 21, 2004; 279(21): 22118 - 22123.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
N. R. Murray, L. Jamieson, W. Yu, J. Zhang, Y. Gokmen-Polar, D. Sier, P. Anastasiadis, Z. Gatalica, E. A. Thompson, and A. P. Fields
Protein kinase C{iota} is required for Ras transformation and colon carcinogenesis in vivo
J. Cell Biol., March 15, 2004; 164(6): 797 - 802.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. C. Gustafson, S. Ray, L. Jamieson, E. A. Thompson, A. R. Brasier, and A. P. Fields
Bcr-Abl Regulates Protein Kinase C{iota} (PKC{iota}) Transcription via an Elk1 Site in the PKC{iota} Promoter
J. Biol. Chem., March 5, 2004; 279(10): 9400 - 9408.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Wang, Y. Anini, W. Wei, X. Qi, A.-M. O'Carroll, T. Mochizuki, H.-Q. Wang, M. R. Hellmich, E. W. Englander, and G. H. Greeley Jr.
Apelin, a New Enteric Peptide: Localization in the Gastrointestinal Tract, Ontogeny, and Stimulation of Gastric Cell Proliferation and of Cholecystokinin Secretion
Endocrinology, March 1, 2004; 145(3): 1342 - 1348.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Chen, A. Purohit, E. Halilovic, S. J. Doxsey, and A. C. Newton
Centrosomal Anchoring of Protein Kinase C {beta}II by Pericentrin Controls Microtubule Organization, Spindle Function, and Cytokinesis
J. Biol. Chem., February 6, 2004; 279(6): 4829 - 4839.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Subbaramaiah, T. P. Marmo, D. A. Dixon, and A. J. Dannenberg
Regulation of Cyclooxgenase-2 mRNA Stability by Taxanes: EVIDENCE FOR INVOLVEMENT OF p38, MAPKAPK-2, and HuR
J. Biol. Chem., September 26, 2003; 278(39): 37637 - 37647.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement